who we are
TAP was the world’s first push-button blood collection device, transforming the way we draw blood by making the process less painful, easy, and more convenient.
Traditional methods of blood draw through venipuncture usually require a visit to a clinic, lab or healthcare professional; where fingersticks typically involve discomfort and anxiety for the patient.
Our improved TAP II device allows patients to continue to easily draw with less pain and from the comfort of home or any other location they choose.
TAP II is placed on the upper arm and blood collection starts with a simple press of a button. The process typically takes 2-3 minutes. This innovation provides easier and more cost-effective access to high quality central lab testing and is a game-changer for consumers, the health care system, and patients.
- TAP II is currently CE Marked and available in select European countries.
- TAP II is available for investigational use only (IUO) in the US and is not yet FDA cleared.
Chief Operating Officer
Chief Medical Officer
Sara Gilbert Leonard
Chief Marketing Officer
Commercial Director, UK and EU
Director of Engineering
Director of Quality
our board of directors
Thomas J. Cahill, MD, PhDFounder and Managing Partner,
Newpath Partners LLC
Don HardisonPresident, CEO and
Director of Biotheranostics, Inc.
Peter Hutt, JDSenior Counsel,
Covington & Burling, LLP
Robert Langer, SCD(Co-founder)
Institute Professor, MIT
Harry WilcoxGeneral Partner,
Ara DarziChairman, Preemptive Medicine
and Health Security Initiative,